...
首页> 外文期刊>Synapse >Measurement of glycine binding site of N-methyl-D-asparate receptors in living human brain using 4-acetoxy derivative of L-703,717, 4-Acetoxy-7-chloro-3-[3-(4-[C-11] methoxybenzyl) phenyl]-2(1H)-quinolone (AcL703) with positron emission tomography
【24h】

Measurement of glycine binding site of N-methyl-D-asparate receptors in living human brain using 4-acetoxy derivative of L-703,717, 4-Acetoxy-7-chloro-3-[3-(4-[C-11] methoxybenzyl) phenyl]-2(1H)-quinolone (AcL703) with positron emission tomography

机译:使用L-703,717的4-乙酰氧基衍生物,4-乙酰氧基-7-氯-3- [3-(4- [C-11]]甲氧基苄基的测定活人脑中N-甲基-D-天冬氨酸受体的甘氨酸结合位点)苯基] -2(1H)-喹诺酮(AcL703),正电子发射断层扫描

获取原文
获取原文并翻译 | 示例

摘要

N-methyl-D-aspartate (NMDA) receptors are of major interest in brain functions and neuropsychiatric disorders. However, at present there are few suitable radioligands for in vivo imaging of NMDA receptors. 7-Choloro-4-hydroxy-3[3-(4-methoxybenzyl) phenyl]-2(1H)-quinolone (L-703,717) is one of the potent ligands for the glycine-binding site of NMDA receptors. 4-Acetoxy derivative of L-703,717 (AcL703) is a candidate, as a positron emission tomography (PET) ligand for NMDA receptors, because of its better permeability at the blood-brain barrier compared with L-703,717. After intravenous injection of 624-851 MBq of [C-11]AcL703, dynamic PET scan was performed on six healthy males for 90 min. Regions-of-interest were located on the cerebral cortices, cerebellar cortex, and cerebral white matter. The binding potential (BP) was calculated from the ratio of the area under the curve (AUC) of radioactivities from 40 to 90 min in the target region to that in white matter. Regional radioactivities reached close to equilibrium in all regions after about 40 min postinjection. Regional brain uptake of [C-11]AcL703 at 40 min after injection was 0.00028-0.00065% of the injected dose/milliliter. Radioactivity concentration of [C-11]AcL703 was highest in the cerebellar cortex and lowest in white matter. AUC in the cerebellar cortex was higher than those of cerebral cortices, thalamus, striatum, and white matter. BP in the cerebellar cortex was twofold higher than in the cerebral cortices (cerebellar cortex: BP = 2.20 +/- 0.72; cerebral cortices: BP = 1.05 +/- 0.45). Despite the low brain uptake of [C-11]AcL703, regional distributions were in good agreement with our previous studies of rodents. This indicates the possibility of in vivo evaluation of NMDA receptors using PET with [C-11]AcL703 in living human brain. Synapse 61:795-800, 2007. (C) 2007 Wiley-Liss, Inc.
机译:N-甲基-D-天门冬氨酸(NMDA)受体在脑功能和神经精神疾病中具有重大意义。然而,目前很少有合适的放射性配体用于NMDA受体的体内成像。 7-氯代-4-羟基-3 [3-(4-甲氧基苄基)苯基] -2(1H)-喹诺酮(L-703,717)是NMDA受体甘氨酸结合位点的有效配体之一。 L-703,717的4-乙酰氧基衍生物(AcL703)是候选药物,是NMDA受体的正电子发射断层扫描(PET)配体,因为与L-703,717相比,它在血脑屏障中的通透性更好。静脉注射[C-11] AcL703 624-851 MBq后,对六名健康男性进行动态PET扫描90分钟。感兴趣区域位于大脑皮层,小脑皮层和脑白质上。结合电位(BP)是根据目标区域中放射活性从40到90分钟的曲线下面积(AUC)与白质中的放射性曲线下面积(AUC)之比计算得出的。注入约40分钟后,所有地区的区域放射性均接近平衡。注射后40分钟,[C-11] AcL703的局部脑摄取为注射剂量/毫升的0.00028-0.00065%。 [C-11] AcL703的放射性浓度在小脑皮层中最高,在白质中最低。小脑皮层的AUC高于脑皮层,丘脑,纹状体和白质。小脑皮层的BP比脑皮层的BP高两倍(小脑皮层:BP = 2.20 +/- 0.72;脑皮层:BP = 1.05 +/- 0.45)。尽管[C-11] AcL703的大脑摄取量较低,但区域分布与我们先前对啮齿动物的研究非常吻合。这表明在活的人脑中使用带有[C-11] AcL703的PET体内评估NMDA受体的可能性。突触61:795-800,2007.(C)2007 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号